Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 17.62B | 16.51B | 15.47B | 8.79B | 8.20B |
Gross Profit | 2.21B | 1.97B | 1.73B | 1.39B | 1.46B |
EBITDA | 762.00M | 766.00M | 732.00M | 655.00M | 819.00M |
Net Income | -309.00M | -128.00M | -576.00M | 247.00M | 467.00M |
Balance Sheet | |||||
Total Assets | 33.25B | 31.40B | 30.52B | 28.57B | 13.01B |
Cash, Cash Equivalents and Short-Term Investments | 976.00M | 826.00M | 810.00M | 1.25B | 2.17B |
Total Debt | 4.66B | 3.70B | 3.69B | 2.93B | 1.64B |
Total Liabilities | 24.48B | 22.29B | 21.49B | 19.45B | 9.68B |
Stockholders Equity | 8.67B | 9.00B | 8.91B | 9.04B | 3.27B |
Cash Flow | |||||
Free Cash Flow | -567.00M | 175.00M | -1.00B | -720.00M | 202.00M |
Operating Cash Flow | -82.00M | 606.00M | -577.00M | -455.00M | 476.00M |
Investing Cash Flow | -431.00M | -478.00M | -443.00M | -1.94B | -368.00M |
Financing Cash Flow | 696.00M | -61.00M | 558.00M | 1.46B | -1.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $19.85B | 28.92 | 40.09% | 0.22% | 26.33% | 63.32% | |
78 Outperform | $15.19B | 41.24 | 16.35% | 0.41% | 4.96% | 8.41% | |
75 Outperform | $12.38B | 28.30 | 15.54% | 1.41% | 1.98% | -7.66% | |
72 Outperform | $10.33B | 19.14 | 12.27% | 2.02% | -1.04% | -21.80% | |
67 Neutral | $14.54B | 68.94 | 9.09% | ― | 3.20% | ― | |
65 Neutral | €9.31B | 16.62 | 3.99% | 3.01% | 2.81% | -19.31% | |
56 Neutral | $11.98B | 79.17 | 1.53% | 4.36% | 7.89% | -135.76% |